FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/05/2026
Voltar para busca
Dado oficial do USPTO
AMYLO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
AMYLO
ST13
US500000079401325Classe
9, 10, 42, 44
Pedido
79401325
Registro
7979697
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
15/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 10, 42, 44
Data de depósito
30/05/2024
Data de registro
14/10/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/10/2025
Última transação
15/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
KR
Examinador
FICKES, JERI J
Unidade examinadora
L70
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
B. H. (pessoa física)
Representantes
April L. Besl Dinsmore & Shohl LLP
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Software as a medical device (SaMD)downloadablefor treating Alzheimer's disease; downloadable computer software for data processing in the field of Alzheimer's disease; downloadable computer software for database management in the field of Alzheimer's disease; downloadable software for processing digital images in the field of Alzheimer's disease; downloadable software for processing imagesgraphics and text in the field of Alzheimer's disease; downloadable computer software for diagnosing diseasesAlzheimer's diseasefor medical purposes; downloadable computer software for use in medical decision support systems in the field of Alzheimer's disease; data processing apparatus for use in the field of Alzheimer's disease; downloadable image files of human brains for use in the field of Alzheimer's disease; downloadable electronic documents in the field of image processing for use in treatment of Alzheimer's disease
Classe 10
Medical apparatus for the diagnosis of cerebrovascular diseases; medical apparatus for the diagnosis of neurological diseases; medical apparatus and instruments for predictingdiagnosingtreating Alzheimer's disease; apparatus for carrying-out diagnostic tests for Alzheimer's disease for medical purposes; diagnostic apparatus for diagnosing Alzheimer's disease for medical purposes; radiological diagnostic imaging apparatusPositron Emission Tomography (PET)Computed Tomography (CT)Magnetic Resonance Imager (MRI) for medical purposes relating to diagnosis and treatment of Alzheimer's disease; diagnostic measuring apparatus for medical use for measuring beta-amyloid plaque for use in the diagnosis and tratment of Alzheimer's disease; medical apparatus and instrumentsapparatus for medical diagnostic testing for use in the fields of clinical diagnosis of Alzheimer's disease; automatic analyzers in the nature of PETCTMRI for medical diagnosis of Alzheimer's disease; electromedical diagnostic instruments for diagnosing Alzheimer's disease
Classe 42
Software as a service (SAAS) services featuring software for image processing for use in diagnosis and treatment of Alzheimer's disease; technological and scientific remote monitoring services relating to the function of medical diagnostic devices in the field of Alzheimer's disease; research and development of medical apparatus and instruments for use in Alzheimer's disease medical diagnostic testing for others; research and development of medical equipment for use in Alzheimer's disease medical diagnostic testing; research and development of medical devices for use in Alzheimer's disease medical diagnostic testing; providing technological support servicesproviding technical advice related to the research and development of medical diagnostic instruments for use in diagnosing Alzheimer's disease; technological and scientific monitoring services relating to the function of Alzheimer's disease medical diagnostic instruments; technology consultation in the field of artificial intelligence for use in the field of diagnosing and treating Alzheimer's disease; research and development of diagnostic apparatus for use in diagnosing Alzheimer's disease; computer aided diagnostic testing services for use in diagnosing Alzheimer's disease
Classe 44
Providing medical advice in the field of geriatrics relating to Alzheimer's disease; medical analysis for the diagnosis and treatment of persons with Alzheimer's disease; health care services for treating Alzheimer's disease; remote monitoring of medical data for medical diagnosis and treatment of Alzheimer's disease; medical analysis services for the diagnosis of Alzheimer's disease; medical diagnostic services for Alzheimer's disease; mental health screening services relating to Alzheimer's disease; medical testing services relating to the diagnosis and treatment of Alzheimer's disease; performing diagnosis of Alzheimer's disease; medical advisory services relating to the treatment of degenerative diseasesAlzheimer's disease
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
28/04/2026
FIMP
FINAL DISPOSITION PROCESSED
28/04/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
15/01/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14/01/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
31/12/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
31/12/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
14/10/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
14/10/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/08/2025
PUBO
PUBLISHED FOR OPPOSITION
26/08/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/08/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/07/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
18/07/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/07/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
18/07/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/07/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/06/2025
RFNT
REFUSAL PROCESSED BY IB
17/01/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/12/2024
RFRR
REFUSAL PROCESSED BY MPU
27/12/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/12/2024
CNRT
NON-FINAL ACTION WRITTEN
12/12/2024
DOCK
ASSIGNED TO EXAMINER
12/12/2024
MAFR
APPLICATION FILING RECEIPT MAILED
06/08/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/08/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/08/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AMYLO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.